IgE antibody specific for benzylpenicilloyl determinant

IgE antibody specific for the benzylpenicilloyl determinant is an immunoglobulin E class antibody produced by B cells in sensitized individuals following exposure to benzylpenicillin (Penicillin G). When penicillin’s β-lactam ring opens and covalently binds to host proteins, the predominant product is the benzylpenicilloyl determinant, which represents the major antigenic structure that induces IgE-mediated allergic responses. Detection of specific IgE against this determinant forms the basis of diagnostic tests for penicillin allergy, including skin testing with benzylpenicilloyl polylysine. Upon re-exposure, cross-linking of these IgE molecules on effector cells like mast cells and basophils can trigger rapid allergic reactions, ranging from urticaria to life-threatening anaphylaxis.\n\nNotes:\n- This entity represents a class of antibodies (IgE specific for a defined chemical determinant), not a protein receptor or enzyme.\n- It is considered a therapeutic target only in the context of allergy testing and risk stratification, not as a classic druggable target.\n- Mechanistic and diagnostic relevance is well established, but not all sources would consider this a “receptor” in the canonical pharmacological sense.\n- The primary clinical interaction is with testing agents rather than with therapeutic drugs directly, although the underlying mechanism drives adverse drug reactions.

Other names

IgE anti-benzylpenicilloyl antibodyanti-BPO IgEpenicillin-specific IgEpenicilloyl-specific IgE

Recognition of benzylpenicilloyl determinant via specific Fab regions of IgE\nInitiation of immediate hypersensitivity reaction (type I), leading to mast cell and basophil degranulation upon subsequent exposure to the determinant